Variant report
Variant | esv3324819 |
---|---|
Chromosome Location | chr1:180183629-180184677 |
allele | n/a |
Outlinks | Ensembl   UCSC |
- TF binding region (count:0)
- CpG islands (count:0)
- Chromatin interactive region (count:4)
- LncRNA region (count:0)
- Mature miRNA region (count: 0)
- miRNA target sites (count:0)
No data |
No data |
(count:4 , 50 per page) page:
1
No. | Distal block | Cell Line | Cell type | Cell Stage |
---|---|---|---|---|
1 | chr1:180183081..180185563-chr1:180187908..180189784,2 | K562 | blood: | |
2 | chr1:180183763..180186747-chr1:180199591..180203355,3 | MCF-7 | breast: | |
3 | chr1:180179618..180183395-chr1:180184350..180187119,5 | K562 | blood: | |
4 | chr1:180183289..180186252-chr1:180197125..180198628,2 | MCF-7 | breast: |
No data |
No data |
No data |
No data |

No. | Variant name | Chromosome position | Chromatin state | Related regulatory elements | Target genes | Extended variants | Associated traits |
---|---|---|---|---|---|---|---|
1 | rs542974472 | chr1:180183662-180183663 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
2 | rs10913950 | chr1:180183676-180183677 | Weak transcription Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
3 | rs147419361 | chr1:180183677-180183678 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
4 | rs545189694 | chr1:180183792-180183793 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
5 | rs564838418 | chr1:180183873-180183874 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
6 | rs527333833 | chr1:180183875-180183876 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
7 | rs556655482 | chr1:180183883-180183884 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
8 | rs568850780 | chr1:180183902-180183903 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
9 | rs547167783 | chr1:180183952-180183953 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
10 | rs560973797 | chr1:180183955-180183956 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
11 | rs539123027 | chr1:180183990-180183991 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
12 | rs557839783 | chr1:180184009-180184010 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
13 | rs573074026 | chr1:180184013-180184014 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
14 | rs534018250 | chr1:180184036-180184037 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
15 | rs61809100 | chr1:180184073-180184074 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
16 | rs61809101 | chr1:180184079-180184080 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
17 | rs61809102 | chr1:180184093-180184094 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
18 | rs61809103 | chr1:180184097-180184098 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
19 | rs61809104 | chr1:180184103-180184104 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
20 | rs61809105 | chr1:180184104-180184105 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
21 | rs61809106 | chr1:180184111-180184112 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
22 | rs56000377 | chr1:180184130-180184131 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
23 | rs55793551 | chr1:180184146-180184147 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
24 | rs201635154 | chr1:180184149-180184150 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
25 | rs202178842 | chr1:180184150-180184151 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
26 | rs73042408 | chr1:180184188-180184189 | Weak transcription Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
27 | rs139085968 | chr1:180184209-180184210 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
28 | rs113900592 | chr1:180184237-180184238 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
29 | rs199900406 | chr1:180184252-180184253 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
30 | rs549195431 | chr1:180184311-180184312 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
31 | rs571748459 | chr1:180184350-180184351 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
32 | rs142308541 | chr1:180184401-180184402 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
33 | rs184164491 | chr1:180184466-180184467 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
34 | rs12568364 | chr1:180184469-180184470 | Weak transcription Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
35 | rs10913951 | chr1:180184479-180184480 | Weak transcription Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
36 | rs116052619 | chr1:180184567-180184568 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
37 | rs544870142 | chr1:180184583-180184584 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
38 | rs564549434 | chr1:180184586-180184587 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
39 | rs4652485 | chr1:180184644-180184645 | Weak transcription Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
40 | rs79709603 | chr1:180184664-180184665 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
41 | rs568715462 | chr1:180184676-180184677 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
Disease | PMID | Source |
---|---|---|
Breast cancer | 17603634 | CNVD |
Esophageal squamous carcinoma | 21637470 | CNVD |
HIV/AIDS | 22032296 | CNVD |
Schizophrenia | 19415332 | CNVD |
Autism | 22495311 | CNVD |
Hepatocellular carcinoma | 16750200 | CNVD |
Liposarcoma | 21253554 | CNVD |
Burkitt''s lymphoma | 18698080 | CNVD |
Melanoma | 18172304 | CNVD |
Cancer | 21183584 | CNVD |
Multiple myeloma | 16461302 | CNVD |
Rett syndrome | 21593744 | CNVD |
Cancer | 20164919 | CNVD |
Medulloblastoma | 21979893 | CNVD |
Acute lymphoblastic leukemia | 17443227 | CNVD |
Wilms tumour | 21544195 | CNVD |
Breast cancer | 17133270 | CNVD |
Non-small cell lung cancer | 21829676 | CNVD |
Carcinoma ex pleomorphic adenoma | 18828159 | CNVD |
Non-small cell lung cancer | 21044232 | CNVD |
Cervical cancer | 21063398 | CNVD |
Acute lymphoblastic leukemia | 20435627 | CNVD |
Astrocytoma | 17387387 | CNVD |
Breast cancer | 20632083 | CNVD |
Endometrial cancer | 22040021 | CNVD |
Ewing''s sarcoma | 21437220 | CNVD |
Gastrointestinal stromal cancer | 20470368 | CNVD |
Glioblastoma multiforme | 19960244 | CNVD |
Glioblastoma multiforme | 21080181 | CNVD |
Hepatocellular carcinoma | 22174799 | CNVD |
Medulloblastoma | 21292688 | CNVD |
Phyllodes tumor | 17334353 | CNVD |
Breast cancer | 21264507 | CNVD |
Multiple myeloma | 21628407 | CNVD |
Cancer | 16751803 | CNVD |
Prostate cancer | 16705090 | CNVD |
Neuroblastoma | 19435921 | CNVD |
Breast cancer | 17850661 | CNVD |
Breast cancer | 16461572 | CNVD |
Intracranial tumor | 16823260 | CNVD |
Medulloblastoma | 18056178 | CNVD |
Monoclonal gammopathy of undetermined significance | 17077331 | CNVD |
Primary mediastinal b-cell lymphoma | 17728785 | CNVD |
Colorectal cancer | 16272173 | CNVD |
Acute lymphoblastic leukemia | 21098271 | CNVD |
Neuroblastoma | 21899760 | CNVD |
Bladder cancer | 19088036 | CNVD |
Ovarian neoplasms | 16753589 | CNVD |
Glioblastoma multiforme | 17002787 | CNVD |
Breast cancer | 21858162 | CNVD |
Non-small cell lung cancer | 21385341 | CNVD |
Acute lymphoblastic leukemia | 21980252 | CNVD |
Breast cancer | 16608533 | CNVD |
Ewing''s sarcoma | 22429812 | CNVD |
Acute promyelocytic leukemia | 19109227 | CNVD |
Chordoma | 18071362 | CNVD |
Hepatocellular carcinoma | 18803288 | CNVD |
Basal cell lymphoma | 16317097 | CNVD |
Diffuse large b-cell lymphoma | 16317097 | CNVD |
Breast cancer | 17001317 | CNVD |
Urothelial carcinoma | 21177765 | CNVD |
Acute myeloid leukemia | 21251322 | CNVD |
Multiple myeloma | 17550852 | CNVD |
Prostate cancer | 18632612 | CNVD |
Acute myeloid leukemia | 20729466 | CNVD |
Hodgkin''s lymphoma | 17606441 | CNVD |
Testicular germ cell tumor | 18059402 | CNVD |
Trisomy 5 syndrome | 21098271 | CNVD |
Ependymoma | 18628472 | CNVD |
Leukemia | 18628472 | CNVD |
Neuroblastoma | 18923191 | CNVD |
Chronic lymphocytic leukemia | 21546498 | CNVD |
Ewing''s sarcoma | 17952124 | CNVD |
Acute lymphoblastic leukemia | 19100363 | CNVD |
small cell lung cancer | 20016488 | CNVD |
Lung cancer | 18438408 | CNVD |
Breast cancer | 21509527 | CNVD |
Glioblastoma multiforme | 17369134 | CNVD |
Cancer | 17440070 | CNVD |
Endometrioid adenocarcinoma | 16974079 | CNVD |
Breast cancer | 21611746 | CNVD |
Breast cancer | 16397240 | CNVD |
Mental retardation | 17847001 | CNVD |
Myelofibrosis | 22110671 | CNVD |
Breast cancer | 23248035 | CNVD |
Metanephric adenoma | 20802469 | CNVD |
Autism | 20841430 | CNVD |
No. | Chromosome Location | Chromatin state | Cell line | Tissue |
---|---|---|---|---|
1 | chr1:180164800-180187800 | Weak transcription | Right Atrium | heart |
2 | chr1:180183200-180184200 | Weak transcription | HSMMtube | muscle |
3 | chr1:180183200-180184400 | Enhancers | Dnd41 | blood |
4 | chr1:180183200-180184600 | Weak transcription | NHLF | lung |
5 | chr1:180183200-180187600 | Weak transcription | iPS DF 19.11 Cell Line | embryonic stem cell |
6 | chr1:180183400-180184400 | Weak transcription | Fetal Lung | lung |
7 | chr1:180183400-180186000 | Weak transcription | Fetal Muscle Leg | muscle |
8 | chr1:180184000-180184400 | Weak transcription | Spleen | Spleen |
9 | chr1:180184400-180186600 | Enhancers | Fetal Lung | lung |